Repligen Price Target Lowered to $190 From $200 at JPMorgan
Wolfe Research Upgrades Repligen to Outperform From Peerperform
Repligen Targets 10% to 15% Growth in Proteins for 2025 Following New Resin Launches
William Blair Maintains Repligen(RGEN.US) With Buy Rating
Repligen's Strong Q1 Performance and Strategic Acquisition Justify Buy Rating
Repligen Corp Q1 Profit Increases, Beats Estimates
Express News | Repligen Corp: Working to Navigate Through Current Economic Environment and See Minimal Impact From Tariffs on EPS
Express News | Repligen Corp FY2025 Shr View $1.71, Rev View $700.4 Mln -- LSEG IBES Data
Express News | Repligen Corp: Reiterates 2025 Full Year Organic Revenue Guidance of 9.5% - 13.5%
Repligen | 8-K: Repligen Reports First Quarter 2025 Financial Results
Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q1 Revenue $169.2M, Vs. FactSet Est of $163.7M
Express News | Repligen Outlook FY Revenue USD 695-720 Million
GUIDANCE: (RGEN) REPLIGEN CORPORATION Expects Fiscal Year 2025 Adjusted EPS Range $1.63 - $1.72
Express News | Repligen Q1 Revenue USD 169 Million Vs. IBES Estimate USD 163.8 Million
Express News | Repligen Q1 Adjusted Operating Income USD 23 Million Vs. IBES Estimate USD 18 Million
Press Release: Repligen Reports First Quarter 2025 Financial Results
Repligen 1Q Net $5.83M >RGEN
Repligen 1Q EPS 10c >RGEN
Earnings Scheduled For April 29, 2025
Here's the Major Earnings Before the Open Tomorrow